Open AccessCOLISTIN: adult and paediatric guideline for South Africa, 2016
Author(s) -
Quinten Labuschagne,
Natalie Schellack,
A. G. S. Prof. Gous,
Elmien Bronkhorst,
Gustav Schellack,
Lindie Van Tonder,
Archele Truter,
Caroline Smith,
Ruth Lancaster,
Sonya Kolman
Publication year - 2016
Publication title -
southern african journal of infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2313-1810
pISSN - 2312-0053
DOI - 10.4102/sajid.v31i1.95
Subject(s) - colistin , dosing , medicine , intensive care medicine , guideline , carbapenem , antibiotics , pharmacology , biology , microbiology and biotechnology , pathology
This document was created to serve as a guideline for colistin prescribing in South Africa. Antimicrobial resistance is threatening the effective prevention and treatment of a wide variety of infections, especially those that are caused by multi-drug-resistant (MDR) gram-negative bacteria. Colistin is typically used as salvage therapy, or last-line treatment, for MDR gram-negative infections. The dosing regimen should be optimised to be therapeutic and halt the emergence of resistance, whilst minimizing toxicity. This document provides evidence-based recommendations for adult and paediatric dosing, dosing in renal impairment, and the use of combination therapy to increase synergistic effects, as well as guidelines on the reconstitution and administration of colistin. This guideline is specifically aimed at healthcare workers who routinely treat patients with MDR gram-negative infections, especially in the intensive care setting.